Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not
FDA Law Blog: Biosimilars
FEBRUARY 11, 2024
Few would oppose FDA-approved marijuana-derived medications if marijuana compounds are found to have medical value; the National Institute of Health should continue to fund research on any potential medical value of marijuana and on the harms of highly potent products.
57 
Let's personalize your content